During the past decade, MGH for Children - Waltham conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MGH for Children - Waltham" are "Ulcerative Colitis" (2 trials), "Crohn's Disease" (1 trials), "Inflammatory Bowel Diseases" (1 trials) and "Ulcerative Colitis Chronic" (1 trials). Many other conditions were trialed in "MGH for Children - Waltham" in a lesser frequency.

Most popular intervention types in "MGH for Children - Waltham" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "MGH for Children - Waltham" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MGH for Children - Waltham". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MGH for Children - Waltham, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MGH for Children - Waltham, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".